SPONSORED CONTENT
An HIV diagnosis does not have the same meaning today as when the virus first emerged in the 1980s. People living with HIV can now expect to live a long, full life, as long as they adhere to a prescribed antiretroviral treatment regimen.
…SPONSORED CONTENT
Since its introduction in 1992, the 340B Program has vastly altered the pharmacy landscape. In these very uncertain times, as we continue to grasp COVID-19’s longevity and struggle to predict a tumultuous 340B environment, we see considerable talk about 340B optimization. From expanding contract pharmacy networks
…SPONSORED CONTENT
Finance guys like myself often have the reputation of being unwilling to spend money. However, we can always be convinced to invest in activities with a high likelihood of return.
The financial pressures of the last year have underscored the importance of the 340B program and its impact on hospital finances. Against the backdrop
…SPONSORED CONTENT by Tyler Curry-McGrath, Avita Pharmacy
A patient newly diagnosed with HIV can often feel as if the cards are stacked against them before they even begin. Overcoming the fear and stigma of telling loved ones, finding the right doctor, navigating the insurance process, starting and staying in care—the journey ahead can seem like an impossible
…SPONSORED CONTENT by Jerry Buller
The challenges that ‘white bagging’ poses for patients and providers are gaining attention as more health plans mandate these policies. ‘White bagging’ disrupts traditional ‘buy-and-bill’ practices for provider-administered drugs, creating patient safety concerns, operational problems, and financial challenges for covered entities.
SPONSORED CONTENT by Dr. LeeAnn Scheer, Caravan Health
Safety net facilities are celebrating the May 17 HRSA letters to six drug manufacturers affirming they must provide drugs to covered entities through their contract pharmacies at the 340B ceiling price. This decision will help these facilities, many of them rural, stretch this federal program
…SPONSORED CONTENT by Kristin Fox-Smith and William Wood, Visante
Those of us actively engaged in the 340B Program are well aware of the scores of issues faced by participating hospitals and it’s not surprising since they account for an exceptionally large percentage of all HRSA audits. But, what about other types
…SPONSORED CONTENT
By: Diana Sierra, MPH, VP, Contract Pharmacy Partnership & RVS Operations, Sentry Data Systems
For years, covered entities generated savings from the 340B program largely by contracting with retail pharmacies. Brick-and-mortar storefronts in their local communities, many of them trailblazing independent pharmacies, provided the most benefit for covered entities in the
…SPONSORED CONTENT by Ross Halsne
It’s becoming increasingly difficult for Covered Entities (CEs) to effectively manage their 340B pharmacy programs. Often times understaffed relative to the task of handling the myriad of challenges that come with managing a 340B program, they face a seemingly constant barrage of maneuvering and attacks aimed at reducing their 340B benefit. In response, many Covered Entities are evaluating new strategies to strengthen or reinvigorate
…There are several ways to enhance, boost, and optimize 340B savings. This white paper looks at how capturing referrals can benefit a covered entity’s 340B program savings and mission.
HRSA GUIDELINES REGARDING REFERRALS
According to HRSA guidelines, a covered entity may send a patient to an outside clinic not registered with 340B and consider
…*Sign up for news summaries and alerts from 340B Report
